Riskpilot← Back to searchSign inGet full accessVINSTRA SYNSENTER AS
ASActiveOrg 927020645Furulundvegen 15, 2640 VinstraRetail sale of medical and orthopaedic goods · NACE 4774Est. 20214 employees
Revenue 2025
NOK 6,9M
+4% vs 2024
EBITDA margin
16.9%
+23% vs 2024
Equity ratio
22.8%
Financial strength
Net profit 2025
NOK 792K
+29% vs 2024
| Revenue | NOK 6,9M | +4% |
| EBITDA | NOK 1,2M | +23% |
| Net profit | NOK 792K | +29% |
| Total assets | NOK 2,4M | +15% |
| Equity | NOK 541K | -1% |
| Employees | 4 | — |
Legal name
VINSTRA SYNSENTER AS
Org number
927020645
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
26. april 2021
Share capital
NOK 400 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Salg av optiske tjenester, tilvirkning og salg av briller og solbriller, samt salg av kontaktlinser og kontaktlinsetilbehør.
Address
Furulundvegen 15, 2640 Vinstra
Phone
+4795252640
Email
post@vinstrasynsenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 975 | 6 059 | 6 298 | 6 597 | 6 859 |
| Staff expenses | −1 019 | −2 655 | −3 146 | −3 177 | −3 152 |
| EBITDA | 678 | 1 172 | 817 | 942 | 1 162 |
| Depreciation & amort. | −95 | −181 | −181 | −171 | −167 |
| EBIT | 583 | 991 | 636 | 771 | 996 |
| Net financials | −15 | 8 | 24 | 24 | 34 |
| Profit before tax | 568 | 999 | 660 | 795 | 1 030 |
| Tax | 124 | 216 | 146 | 183 | 237 |
| Net profit | 444 | 783 | 514 | 612 | 792 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 354 | 2 653 | 1 786 | 2 062 | 2 366 |
| Equity | 838 | 422 | 536 | 548 | 541 |
| Long-term debt | 887 | 53 | 18 | 0 | 0 |
| Short-term debt | 628 | 2 179 | 1 232 | 1 514 | 1 825 |
| Total debt | 1 515 | 2 232 | 1 250 | 1 514 | 1 825 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20212025
Equity ratio
22.8%
This company
38.2%
Market median
-40% vs market
20212025
Return on equity
146.6%
This company
18.4%
Market median
+697% vs market
20212025
Net profit margin
11.6%
This company
8.1%
Market median
+43% vs market
20212025
Asset turnover
2.90×
This company
1.12×
Market median
+159% vs market
20212025
Debt / equity
3.38×
This company
0.62×
Market median
-445% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BB Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
BB Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Stokkevåg Holding As
VINSTRA SYNSENTER AS Board members of VINSTRA SYNSENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørg Blomberg Kolås | Chief Executive Officer | 0 companies |
| Bjørg Blomberg | Chief Executive Officer | 0 companies |
| Ole Flækøy | Board of Directors | 0 companies |
| Roald Lien | Board of Directors | 0 companies |
| Lene Stokkevåg Eide | Chairman | 0 companies |